Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes : The EPIC-InterAct Case-Cohort Study

Author

  • Nita G. Forouhi
  • Fumiaki Imamura
  • Stephen J. Sharp
  • Albert Koulman
  • Matthias B. Schulze
  • Jusheng Zheng
  • Zheng Ye
  • Ivonne Sluijs
  • Marcela Guevara
  • José María Huerta
  • Janine Kröger
  • Laura Yun Wang
  • Keith Summerhill
  • Julian L. Griffin
  • Edith J M Feskens
  • Aurélie Affret
  • Pilar Amiano
  • Heiner Boeing
  • Courtney Dow
  • Guy Fagherazzi
  • Paul W. Franks
  • Carlos Gonzalez
  • Rudolf Kaaks
  • Timothy J. Key
  • Kay Tee Khaw
  • Tilman Kühn
  • Lotte Maxild Mortensen
  • Peter M. Nilsson
  • Kim Overvad
  • Valeria Pala
  • Domenico Palli
  • Salvatore Panico
  • J. Ramón Quirós
  • Miguel Rodriguez-Barranco
  • Olov Rolandsson
  • Carlotta Sacerdote
  • Augustin Scalbert
  • Nadia Slimani
  • Annemieke M W Spijkerman
  • Anne Tjonneland
  • Maria Jose Tormo
  • Rosario Tumino
  • Daphne L. van der A
  • Yvonne T. van der Schouw
  • Claudia Langenberg
  • Elio Riboli
  • Nicholas J. Wareham

Summary, in English

Background: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. Methods and Findings: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. Conclusions: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class.

Department/s

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2016-07-01

Language

English

Publication/Series

PLoS Medicine

Volume

13

Issue

7

Document type

Journal article

Publisher

Public Library of Science

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 1549-1277